Heide Zerban

2.1k total citations
52 papers, 1.5k citations indexed

About

Heide Zerban is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Heide Zerban has authored 52 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 14 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Heide Zerban's work include Renal and related cancers (6 papers), Amino Acid Enzymes and Metabolism (5 papers) and Renal cell carcinoma treatment (4 papers). Heide Zerban is often cited by papers focused on Renal and related cancers (6 papers), Amino Acid Enzymes and Metabolism (5 papers) and Renal cell carcinoma treatment (4 papers). Heide Zerban collaborates with scholars based in Germany, Belarus and Taiwan. Heide Zerban's co-authors include Peter Bannasch, Werner W. Franke, Rainer Krech, Jürgen Kartenbeck, T.W. Keenan, Fritz Klimek, E Schmid, Annette Kopp‐Schneider, Mario Berger and Malcolm A Moore and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Cell Biology and Hepatology.

In The Last Decade

Heide Zerban

52 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heide Zerban Germany 24 682 320 249 231 174 52 1.5k
J Frei Canada 21 515 0.8× 297 0.9× 113 0.5× 233 1.0× 73 0.4× 45 1.3k
Anne R. Kinsella United Kingdom 25 1.3k 1.8× 350 1.1× 156 0.6× 669 2.9× 150 0.9× 48 2.2k
Norifumi Ueda Japan 23 803 1.2× 213 0.7× 197 0.8× 245 1.1× 167 1.0× 62 1.6k
Olav Hilmar Iversen Norway 18 427 0.6× 239 0.7× 230 0.9× 232 1.0× 88 0.5× 107 1.3k
Aaron E. Freeman United States 18 555 0.8× 281 0.9× 107 0.4× 243 1.1× 127 0.7× 36 1.4k
L. Santi Italy 17 788 1.2× 669 2.1× 128 0.5× 639 2.8× 316 1.8× 70 2.2k
Barbara A. Olson United States 18 886 1.3× 132 0.4× 66 0.3× 259 1.1× 98 0.6× 45 1.8k
K Goerttler Germany 21 468 0.7× 294 0.9× 232 0.9× 238 1.0× 78 0.4× 98 1.2k
K. Lapis Hungary 28 1.1k 1.6× 392 1.2× 413 1.7× 537 2.3× 158 0.9× 232 2.4k
Cho‐Rok Jung South Korea 29 1.2k 1.8× 334 1.0× 148 0.6× 399 1.7× 224 1.3× 87 2.4k

Countries citing papers authored by Heide Zerban

Since Specialization
Citations

This map shows the geographic impact of Heide Zerban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heide Zerban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heide Zerban more than expected).

Fields of papers citing papers by Heide Zerban

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heide Zerban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heide Zerban. The network helps show where Heide Zerban may publish in the future.

Co-authorship network of co-authors of Heide Zerban

This figure shows the co-authorship network connecting the top 25 collaborators of Heide Zerban. A scholar is included among the top collaborators of Heide Zerban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heide Zerban. Heide Zerban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bannasch, Peter & Heide Zerban. (1999). Pathogenesis of Renal Cell Adenomas and Carcinomas in Animal Models. Contributions to nephrology. 128. 99–125. 2 indexed citations
2.
Su, Qin, Heide Zerban, Gerd Otto, & Peter Bannasch. (1998). Cytokeratin expression is reduced in glycogenotic clear hepatocytes but increased in ground-glass cells in chronic human and woodchuck hepadnaviral infection†. Hepatology. 28(2). 347–359. 23 indexed citations
3.
Zerban, Heide, et al.. (1995). Effects of low doses of N-nitrosomorpholine on the development of early stages of hepatocarcinogenesis. Carcinogenesis. 16(7). 1513–1518. 41 indexed citations
4.
Zerban, Heide, et al.. (1994). Preneoplastic foci of altered hepatocytes induced in rats by irradiation with α-particles of Thorotrast and neutrons. Cancer Letters. 83(1-2). 81–88. 9 indexed citations
5.
Ahn, Yuri, Annette Rempel, Heide Zerban, & Peter Bannasch. (1994). Over-expression of glucose transporter isoform GLUT1 and hexokinase I in rat renal oncocytic tubules and oncocytomas. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 425(1). 63–8. 11 indexed citations
6.
7.
Zerban, Heide, et al.. (1992). Glycogen phosphorylase hyperactive foci of altered hepatocytes in aged rats. Virchows Archiv B Cell Pathology Including Molecular Pathology. 62(1). 3–8. 6 indexed citations
8.
Zuna, I., Adolf Lorenz, Heide Zerban, et al.. (1991). Computerized ultrasound B‐scan texture analysis of experimental diffuse parenchymal liver disease: Correlation with histopathology and tissue composition. Journal of Clinical Ultrasound. 19(4). 193–201. 44 indexed citations
9.
Volm, M, Heide Zerban, J Mattern, & Thomas Efferth. (1990). Overexpression of P-glycoprotein rat hepatocellular carcinomas induced with N-nitrosomorpholine. Carcinogenesis. 11(1). 169–172. 22 indexed citations
10.
Bannasch, Peter & Heide Zerban. (1990). Pathology of tumours in laboratory animals. Tumours of the rat. Tumours of the liver.. PubMed. 199–240. 14 indexed citations
11.
Haberkorn, Uwe, et al.. (1989). Quantitative Untersuchungen zum Einfluß von Bindegewebs- und Fettstrukturen auf das Ultraschallbild der Leber. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 151(10). 439–442. 2 indexed citations
12.
Ruan, Yajun, Hans Jörg Hacker, Heide Zerban, & Peter Bannasch. (1989). Ultrastructural and Immunocytochemical Characterization of the Cellular Phenotype in Primary Adenoid Liver Tumours of the Rat. Pathology - Research and Practice. 184(2). 223–233. 4 indexed citations
13.
Zerban, Heide, H. Rabes, & Peter Bannasch. (1989). Sequential changes in growth kinetics and cellular phenotype during hepatocarcinogenesis. Journal of Cancer Research and Clinical Oncology. 115(4). 329–334. 14 indexed citations
14.
Zerban, Heide, R. Preußmann, & Peter Bannasch. (1988). Dose—time relationship of the development of preneoplastic liver lesions induced in rats with low doses of N-nitrosodiethanolamine. Carcinogenesis. 9(4). 607–610. 21 indexed citations
15.
16.
Berger, Martin R., D. Schmähl, & Heide Zerban. (1987). Combination experiments with very low doses of three genotoxic N-nitrosamines with similar organotropic carcinogenidty in rats. Carcinogenesis. 8(11). 1635–1643. 46 indexed citations
17.
Bannasch, Peter, Hans Jörg Hacker, Hiroyuki Tsuda, & Heide Zerban. (1986). Aberrant regulation of carbohydrate metabolism and metamorphosis during renal carcinogenesis. Advances in Enzyme Regulation. 25. 279–284. 31 indexed citations
18.
Franke, Werner W., Heide Zerban, Christine Gründ, & E Schmid. (1981). Electron microscopy of vimentin filaments and associated whisker structures in thin sections and freeze-fractures. Biology of the Cell. 41(3). 173–178. 12 indexed citations
19.
Krech, Rainer, Heide Zerban, & Peter Bannasch. (1981). Mitochondrial anomalies in renal oncocytes induced in rat by N-nitrosomorpholine.. PubMed. 25(2). 331–9. 26 indexed citations
20.
Zerban, Heide, Martin Wehner, & G. Werz. (1973). �ber die Feinstruktur des Zellkerns von Acetabularia nach Gefrier�tzung. Planta. 114(3). 239–250. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Frei Breakdown of academic impact, for papers by Anne R. Kinsella Breakdown of academic impact, for papers by Norifumi Ueda Breakdown of academic impact, for papers by Olav Hilmar Iversen Breakdown of academic impact, for papers by Aaron E. Freeman Breakdown of academic impact, for papers by L. Santi Breakdown of academic impact, for papers by Barbara A. Olson Breakdown of academic impact, for papers by K Goerttler Breakdown of academic impact, for papers by K. Lapis Breakdown of academic impact, for papers by Cho‐Rok Jung
Rankless by CCL
2026